INHIBIKASE THERAPEUTICS INC (IKT)

US45719W2052 - Common Stock

3.2  +0.04 (+1.27%)

After market: 3.27 +0.07 (+2.19%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.